Marimed (MRMD) Cash from Operations (2013 - 2026)

Marimed (MRMD) has 14 years of Cash from Operations data on file, last reported at 949000.0 in Q1 2026.

• Cash from Operations for Q1 2026 came in at 949000.0, down 26.6% year-over-year; the trailing twelve-month figure through Mar 2026 was 7351000.0 (up 51.01% YoY), and the FY2025 annual result was 7695000.0, up 13.41% from the prior year.
• Cash from Operations fell to 949000.0 in Q1 2026 per MRMD's latest filing, from 3429000.0 in the prior quarter.
• Over five years, Cash from Operations peaked at 8490000.0 in Q1 2022 and troughed at 6261000.0 in Q2 2022.
• A 5-year average of 1802941.18 and a median of 1737000.0 in 2022 frame the typical range for Cash from Operations.
• The sharpest annual moves came in 2022 and 2025: Cash from Operations slumped 157.8% in 2022, then jumped 930.27% in 2025.
• A 5-year view of Cash from Operations shows it stood at 1737000.0 in 2022, then jumped by 86.18% to 3234000.0 in 2023, then slumped by 112.77% to 413000.0 in 2024, then jumped by 930.27% to 3429000.0 in 2025, then plunged by 72.32% to 949000.0 in 2026.
• Business Quant data shows MRMD's Cash from Operations at 949000.0 in Q1 2026, 3429000.0 in Q4 2025, and 2676000.0 in Q3 2025.